Fladgate advises WideCells Group PLC on recent placing


Our team: Paul Airley


Fladgate has advised WideCells Group PLC, the healthcare services provider to the stem cell industry, on their recent placing to raise gross funds of approximately £650,000.  The proceeds will be used to take advantage of a number of identified opportunities to accelerate the roll out of its three stem cell services divisions, CellPlan, WideCells and WideAcademy, and further its penetration of the growing stem cell services market.

The Fladgate team was led by capital markets partner Paul Airley.

View by author:


Would you like to hear more?